According to Axios, IBM’s famous artificial intelligence system Watson continues to have difficulty finding investors. IBM once again offered to sell the service the computer provided.
In fact, this is not the first time IBM has attempted to find a project sponsor. Yet another sign that AI has not lived up to its expectations.
“Health care will always tend to be sensitive, and with better reason than other sectors in efforts to regulate,” IBM CEO Arvind Krishna said in an interview last year. “For me, that also comes naturally. It is a decision that affects the life and death of an individual. You just have to be careful. So in healthcare, it turns out we were too optimistic“.
If they buy and sell, Watson will really have the opportunity to make a difference for millions of patients, and at the same time change the macro strategy in healthcare access.
IBM technology group spent more than 4 billion USD to buy a series of large and small healthcare companies, to synthesize into IBM Watson Health with artificial intelligence platform. Talking to Axios, the IBM representative only asked for 1 billion USD in investment, which means that IBM is satisfied with the loss of many billion USD for the artificial intelligence project.
At the end of 2021, IBM asked Bank of America to find investors, both companies declined to provide more relevant information. However, it is known that at least one company with the same level of artificial intelligence has stood out to buy Watson, the information also indicates that many private organizations have also stood the price.
The responsibilities that go along with the Watson project can baffle many buyers. It’s not easy to make a profit with healthcare-related decisions, and if Watson doesn’t find a qualified buyer, the risk won’t stop at the financials.
.